Nasal Polyps
·MeSH: Nasal Polyps
12 drugs in development·7 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(4)
| Drug | Company |
|---|---|
| lunsekimig | Sanofi (SNY) |
| lunsekimig | Sanofi (SNY) |
| LY3650150 | ELI LILLY & Co (LLY) |
| Mometasone furoate nasal spray | Sanofi (SNY) |
Phase 2(3)
| Drug | Company |
|---|---|
| Mometasone furoate nasal spray | INSMED Inc (INSM) |
| verekitug | Upstream Bio, Inc. (UPB) |
| zumilokibart | Apogee Therapeutics, Inc. (APGE) |
BLA Filed(1)
| Drug | Company |
|---|---|
| xhance | OptiNose, Inc. (OPTN) |
Phase 4(4)
| Drug | Company |
|---|---|
| CM326 injection | Crinetics Pharmaceuticals, Inc. (CRNX) |
| itepekimab | Sanofi (SNY) |
| Itepekimab | Sanofi (SNY) |
| omalizumab | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Nasal Polyps?
BioSniper tracks 12 drugs in development for Nasal Polyps across 7 companies.
How many clinical trials target Nasal Polyps?
There are 1 clinical trial targeting Nasal Polyps tracked by BioSniper.
Analyze OptiNose, Inc.'s Nasal Polyps pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company